Concepedia

Merve Atli

MA

Statistics

Publications

4

Citations

226

H-Index

4

Active since

2023

Affiliations

Columbia University(Current)

Emory University

King's College London

Pathways Behavioral Services

University of California San Diego

Merve Atli is an author at Columbia University specializing in psychopharmacology, antidepressant pharmacotherapy, and antidepressant therapy.

Publications per year

2023–2025

4

Publications

4

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez et al. · Journal of Affective Disorders · 2023 · 165 citations · Full text

, , +17

Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions

Namik Kirlić, Molly Lennard-Jones, Merve Atli et al. · American Journal of Psychiatry · 2025 · 26 citations

, , +10

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing

Robert F. Dougherty, Patrick Clarke, Merve Atli et al. · Psychopharmacology · 2023 · 21 citations · Full text

, , +17

Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder

Guy M. Goodwin, Merve Atli, Boadie W. Dunlop et al. · The Journal of Clinical Psychiatry · 2025 · 14 citations

, , +17

1–4 of 4